Home > Resources > Whitepapers > ATPlite assay performance in human primary cells

ATPlite assay performance in human primary cells

July 18, 2018

One of the criteria for a compound to be considered druggable is the ability to cause or block a biological activity without toxic effects in an in vitro setting using primary human cells. As a read-out for compound-induced activity or toxicity, it is common to determine cell proliferation or cell death. Proliferation and cytotoxicity can be by looking at ATP levels in the cell. See how ATPlite and ATPlite 1step serve as robust, rapid, high-throughput luminescence assays to quantitatively evaluate proliferation and cytotoxicity in cultured human primary cells.

Spotlight

Biotech Pharma Services

Biotech Pharma Services is a pharmaceutical and medical equipment company, established 2007 in UAE, with the intention to provide support and services to the health care divisions in the Gulf region, our main focus is the advanced and modern technologies and sciences in the field of pharmacy in the world, like Biotechnology, Nanotechnology, Generic Injectable and Heath Robotic pharmacy workflow systems, and we are committed to the provision of the highest quality of health and medical services for our customers in UAE and the Gulf region.

OTHER WHITEPAPERS

The biopharmaceutical industry is leading the way in developing vaccines and treatments for COVID-19

whitePaper | April 8, 2020

The rapid spread of the novel coronavirus across the globe is a major public health threat for all, with profound health, social and economic impacts around the world. As a science-driven industry that aims to address some of the world’s biggest healthcare challenges, the research-based biopharmaceutical industry is uniquely positioned to respond rapidly to COVID-19. It has deep scientific knowledge gained from decades of experience working on developing solutions for combatting a range of infectious diseases such as MERS, SARS, Ebola and influenza.